December 11, 2013
Webinar
Patents and trade secrets coexist as separate intellectual property regimes, and as a result, businesses and inventors must often choose between patent and trade secret protection. Recent legislative changes, including the America Invents Act (“AIA”) directly affect this choice. For example, under the AIA, the prior user defense preserves the right to continue the practice of a trade secret invention in the United States despite subsequent issuance of a third party patent. The availability of this defense limits the need to patent every commercial improvement and simplifies freedom to operate analysis for commercial processes. With these advantages in mind, trade secrets could in some instances be a desirable alternative to patents. Please join our panel as they highlight issues to consider when choosing between patents and trade secrets in light of recent legislative changes and court decisions. Topics will include:
Martin D. Hyden
Eric P. Raciti
Jennifer H. Roscetti
Date:
Wednesday, December 11, 2013
10:00-11:00 a.m. EST
16:00-17:00 CET
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
May 12, 2026
Webinar
Panel Discussion
May 5, 2026
London
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.